Pharma News

The Food and Drug Administration (FDA) has accepted the investigational new drug (IND) application to trehalose (SLS-005; Seelos Therapeutics, New York, NY) for spinocerebellar ataxia (SCA) treatme...

Today, the U.S. Food and Drug Administration approved Besremi (ropeginterferon alfa-2b-njft) injection to treat adults with polycythemia vera, a blood disease that causes the overproduction of red...

"They have literally cost millions of lives,” Albert Bourla said in an interview with the Atlantic Council.

Europe's drug regulator has recommended two COVID-19 antibody therapies - one from American-Swiss partners Regeneron-Roche and another from South Korea's Celltrion, as the region builds up its defe...

World Diabetes Day provides an opportunity to raise awareness of diabetes as a global public health issue and what needs to be done, collectively and individually, for better prevention, diagnosis...

Prexasertib has been on a more than two decade journey, and that doesn't include commercialization. 

Producers of adenovirus-vectored COVID-19 vaccines have had to deal with more questions about rare side effects than those making mRNA COVID-19 vaccines.

Organon, and Forendo Pharma today announced that the companies have entered into a definitive agreement, under which Organon will acquire Forendo, a clinical-stage drug development company focused ...

The European Commission (EC) has approved an agreement for Valneva to supply up to 60 million doses of the company’s inactivated COVID-19 vaccine candidate VLA2001 over a period of two years. ...

WOBURN, MA – Azurity Pharmaceuticals, Inc. a private specialty pharmaceutical company focused on developing innovative products to meet the unique needs of patients with underserved conditions, ...

Paxlovid (PF-07321332) is an investigational SARS-CoV-2 protease inhibitor antiviral in development for the treatment of non-hospitalized high-risk adults with COVID-19 to prevent severe illness wh...

After months long safety scrutiny, the World Health Organization has included India’s indegenous Covid-19 vaccine – Covaxin in its authorised emergency use list.  ...